Attention: The EBRAINS IDM/IAM will be down tomorrow, Wednesday 17nd December, from 17:00 CET for up to 30 minutes for maintenance. Please be aware that this will affect all services that require login or authentication.


Changes for page Methodology

Last modified by manuelmenendez on 2025/03/14 08:31
From version 23.1
edited by manuelmenendez
on 2025/02/15 12:55
Change comment: There is no comment for this version
To version 22.1
edited by manuelmenendez
on 2025/02/15 12:55
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -11,7 +11,7 @@
11 11  |=**Category**|=**Description**
12 12  |**Molecular Biomarkers**|Omics-based markers (genomic, transcriptomic, proteomic, metabolomic, lipidomic)
13 13  |**Neuroimaging Biomarkers**|Structural (MRI, CT), Functional (fMRI, PET), Molecular Imaging (tau, amyloid, α-synuclein)
14 -|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL, autoantiboides
14 +|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL
15 15  |**Neurophysiological Biomarkers**|EEG, MEG, evoked potentials (ERP), sleep-related markers
16 16  |**Digital Biomarkers**|Gait analysis, cognitive/speech biomarkers, wearables data, EHR-based markers
17 17  |**Clinical Phenotypic Markers**|Standardized clinical scores (MMSE, MoCA, CDR, UPDRS, ALSFRS, UHDRS)